URGN UroGen Pharma | $16.87 -7.7% | 6/14/2024 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $48.00 -> $53.50 | Low | View details for LADENBURG THALM/SH SH rating of UroGen Pharma (NASDAQ:URGN) on 6/14/2024 |
RCAT Red Cat | $1.02 -8.9% | 6/14/2024 | Initiated by | LADENBURG THALM/SH SH | Analyst G. Mattson | Buy | $4.00 | Low | View details for LADENBURG THALM/SH SH rating of Red Cat (NASDAQ:RCAT) on 6/14/2024 |
ETR Entergy | $106.08 -0.3% | 6/12/2024 | Reiterated by | LADENBURG THALM/SH SH | Analyst P. Fremont | Buy -> Neutral | $117.00 -> $109.50 | Low | View details for LADENBURG THALM/SH SH rating of Entergy (NYSE:ETR) on 6/12/2024 |
PNW Pinnacle West Capital | $74.72 -1.5% | 6/6/2024 | Upgraded by | LADENBURG THALM/SH SH | Analyst P. Fremont | Neutral -> Buy | $74.00 -> $83.50 | Low | View details for LADENBURG THALM/SH SH rating of Pinnacle West Capital (NYSE:PNW) on 6/6/2024 |
AEP American Electric Power | $87.55 -0.2% | 6/6/2024 | Upgraded by | LADENBURG THALM/SH SH | Analyst P. Fremont | Sell -> Neutral | $73.00 -> $86.00 | Low | View details for LADENBURG THALM/SH SH rating of American Electric Power (NASDAQ:AEP) on 6/6/2024 |
SRE Sempra | $75.10 +0.3% | 5/29/2024 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $81.50 -> $79.00 | Low | View details for LADENBURG THALM/SH SH rating of Sempra (NYSE:SRE) on 5/29/2024 |
|
CAPR Capricor Therapeutics | $4.84 -2.4% | 5/14/2024 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $24.00 -> $25.00 | Low | View details for LADENBURG THALM/SH SH rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/14/2024 |
RC Ready Capital | $8.40 -1.5% | 5/10/2024 | Downgraded by | LADENBURG THALM/SH SH | Analyst C. Nolan | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Ready Capital (NYSE:RC) on 5/10/2024 |
GAIN Gladstone Investment | $13.84 -1.2% | 5/9/2024 | Reiterated by | LADENBURG THALM/SH SH | Analyst M. Schleien | Buy -> Neutral | $14.00 -> $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Gladstone Investment (NASDAQ:GAIN) on 5/9/2024 |
VRDN Viridian Therapeutics | $12.18 -0.2% | 5/9/2024 | Downgraded by | LADENBURG THALM/SH SH | Analyst M. Higgins | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 5/9/2024 |
TGTX TG Therapeutics | $16.77 +1.2% | 5/2/2024 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $39.00 -> $40.00 | Low | View details for LADENBURG THALM/SH SH rating of TG Therapeutics (NASDAQ:TGTX) on 5/2/2024 |
MRKR Marker Therapeutics | $4.62 -3.3% | 4/30/2024 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $11.00 | Low | View details for LADENBURG THALM/SH SH rating of Marker Therapeutics (NASDAQ:MRKR) on 4/30/2024 |
LNT Alliant Energy | $49.62 -0.1% | 4/29/2024 | Target Lowered by | LADENBURG THALM/SH SH | - | Neutral -> Neutral | $48.50 -> $48.00 | Low | View details for LADENBURG THALM/SH SH rating of Alliant Energy (NASDAQ:LNT) on 4/29/2024 |
ACRV Acrivon Therapeutics | $6.63 -3.6% | 4/29/2024 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Acrivon Therapeutics (NASDAQ:ACRV) on 4/29/2024 |
SR Spire | $58.41 -0.3% | 4/26/2024 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $57.50 | Low | View details for LADENBURG THALM/SH SH rating of Spire (NYSE:SR) on 4/26/2024 |
TGTX TG Therapeutics | $16.77 +1.2% | 4/18/2024 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Buy | $39.00 | Low | View details for LADENBURG THALM/SH SH rating of TG Therapeutics (NASDAQ:TGTX) on 4/18/2024 |
ALRN Aileron Therapeutics | $3.12 -2.8% | 4/18/2024 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $9.00 -> $19.00 | Low | View details for LADENBURG THALM/SH SH rating of Aileron Therapeutics (NASDAQ:ALRN) on 4/18/2024 |
BYRN Byrna Technologies | $10.57 -1.1% | 4/9/2024 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $12.75 -> $16.25 | Low | View details for LADENBURG THALM/SH SH rating of Byrna Technologies (NASDAQ:BYRN) on 4/9/2024 |
FBRX Forte Biosciences | $0.54 +3.9% | 4/8/2024 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $2.75 | Low | View details for LADENBURG THALM/SH SH rating of Forte Biosciences (NASDAQ:FBRX) on 4/8/2024 |
ACRV Acrivon Therapeutics | $6.63 -3.6% | 4/5/2024 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $18.00 -> $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Acrivon Therapeutics (NASDAQ:ACRV) on 4/5/2024 |
EVRG Evergy | $52.80 +0.3% | 4/4/2024 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $51.00 | Low | View details for LADENBURG THALM/SH SH rating of Evergy (NYSE:EVRG) on 4/4/2024 |
INUV Inuvo | $0.24 -7.8% | 4/2/2024 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $1.00 | Low | View details for LADENBURG THALM/SH SH rating of Inuvo (NYSE:INUV) on 4/2/2024 |
EVAX Evaxion Biotech A/S | $2.73 +10.5% | 4/2/2024 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $8.00 | Low | View details for LADENBURG THALM/SH SH rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 4/2/2024 |
SPRB Spruce Biosciences | $0.63 -3.1% | 3/14/2024 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024 |
RWAY Runway Growth Finance | $11.71 -0.3% | 3/8/2024 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
AEP American Electric Power | $87.55 -0.2% | 3/8/2024 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral -> Sell | $75.50 -> $73.00 | Low | View details for LADENBURG THALM/SH SH rating of American Electric Power (NASDAQ:AEP) on 3/8/2024 |
OGS ONE Gas | $60.21 -0.8% | 3/5/2024 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $64.50 | Low | View details for LADENBURG THALM/SH SH rating of ONE Gas (NYSE:OGS) on 3/5/2024 |
HRZN Horizon Technology Finance | $11.77 -0.3% | 2/28/2024 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Horizon Technology Finance (NASDAQ:HRZN) on 2/28/2024 |
PNW Pinnacle West Capital | $74.72 -1.5% | 2/14/2024 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $69.00 | Low | View details for LADENBURG THALM/SH SH rating of Pinnacle West Capital (NYSE:PNW) on 2/14/2024 |
OGS ONE Gas | $60.21 -0.8% | 2/14/2024 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $58.00 | Low | View details for LADENBURG THALM/SH SH rating of ONE Gas (NYSE:OGS) on 2/14/2024 |
SOUN SoundHound AI | $4.09 -4.7% | 1/30/2024 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $4.00 | Low | View details for LADENBURG THALM/SH SH rating of SoundHound AI (NASDAQ:SOUN) on 1/30/2024 |
OGE OGE Energy | $35.11 -0.1% | 1/16/2024 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $36.00 -> $34.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 1/16/2024 |
SRE Sempra | $75.10 +0.3% | 1/3/2024 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $81.50 | Low | View details for LADENBURG THALM/SH SH rating of Sempra (NYSE:SRE) on 1/3/2024 |
ED Consolidated Edison | $90.39 -0.3% | 1/3/2024 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $92.50 | Low | View details for LADENBURG THALM/SH SH rating of Consolidated Edison (NYSE:ED) on 1/3/2024 |
PMVP PMV Pharmaceuticals | $1.61 -2.4% | 12/27/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $7.00 | Low | View details for LADENBURG THALM/SH SH rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 12/27/2023 |
LQDA Liquidia | $12.52 -6.1% | 12/21/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $15.00 -> $30.00 | Low | View details for LADENBURG THALM/SH SH rating of Liquidia (NASDAQ:LQDA) on 12/21/2023 |
EVAX Evaxion Biotech A/S | $2.73 +10.5% | 12/21/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 12/21/2023 |
RPHM Reneo Pharmaceuticals | $1.58 -4.2% | 12/14/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 12/14/2023 |
ONDS Ondas | $0.73 -1.4% | 12/11/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $3.50 | Low | View details for LADENBURG THALM/SH SH rating of Ondas (NASDAQ:ONDS) on 12/11/2023 |
ALRN Aileron Therapeutics | $3.12 -2.8% | 12/1/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $9.00 | Low | View details for LADENBURG THALM/SH SH rating of Aileron Therapeutics (NASDAQ:ALRN) on 12/1/2023 |
Bigger Than NVIDIA? (Ad) With NVIDIA flying high, everyone is looking for the next breakout stock.
But right now...
There's only ONE stock you should be watching. Get the full story here >>> |
OCCI OFS Credit | $7.35 -1.7% | 11/13/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of OFS Credit (NASDAQ:OCCI) on 11/13/2023 |
POR Portland General Electric | $42.42 -1.3% | 11/9/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $43.00 | Low | View details for LADENBURG THALM/SH SH rating of Portland General Electric (NYSE:POR) on 11/9/2023 |
NWE NorthWestern Energy Group | $49.40 -0.3% | 11/7/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $51.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 11/7/2023 |
CPK Chesapeake Utilities | $103.62 -1.1% | 10/12/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $100.00 | Low | View details for LADENBURG THALM/SH SH rating of Chesapeake Utilities (NYSE:CPK) on 10/12/2023 |
OGE OGE Energy | $35.11 -0.1% | 10/12/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $39.00 -> $36.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 10/12/2023 |
ZURA Zura Bio | $3.38 -9.4% | 10/10/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $10.00 | Low | View details for LADENBURG THALM/SH SH rating of Zura Bio (NASDAQ:ZURA) on 10/10/2023 |
NI NiSource | $28.07 +0.3% | 10/6/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $25.00 | Low | View details for LADENBURG THALM/SH SH rating of NiSource (NYSE:NI) on 10/6/2023 |
SABS SAB Biotherapeutics | $2.58 -20.6% | 10/5/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of SAB Biotherapeutics (NASDAQ:SABS) on 10/5/2023 |
COEP Coeptis Therapeutics | $0.32 +3.2% | 9/22/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $3.00 | Low | View details for LADENBURG THALM/SH SH rating of Coeptis Therapeutics (NASDAQ:COEP) on 9/22/2023 |
MRNS Marinus Pharmaceuticals | $1.40 -3.5% | 9/20/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $13.00 -> $15.50 | Low | View details for LADENBURG THALM/SH SH rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 9/20/2023 |
AEP American Electric Power | $87.55 -0.2% | 9/13/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of American Electric Power (NASDAQ:AEP) on 9/13/2023 |
WEC WEC Energy Group | $78.05 -0.4% | 9/11/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $85.00 | Low | View details for LADENBURG THALM/SH SH rating of WEC Energy Group (NYSE:WEC) on 9/11/2023 |
NWE NorthWestern Energy Group | $49.40 -0.3% | 8/17/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $59.00 -> $53.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 8/17/2023 |
CKPT Checkpoint Therapeutics | $1.94 -4.4% | 8/15/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $65.00 -> $47.00 | Low | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 8/15/2023 |
EIX Edison International | $71.39 -0.2% | 8/15/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Edison International (NYSE:EIX) on 8/15/2023 |
CGTX Cognition Therapeutics | $2.01 -8.2% | 8/14/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $10.00 -> $6.00 | Low | View details for LADENBURG THALM/SH SH rating of Cognition Therapeutics (NASDAQ:CGTX) on 8/14/2023 |
PNNT PennantPark Investment | $7.46 -0.5% | 8/14/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $6.50 -> $7.00 | Low | View details for LADENBURG THALM/SH SH rating of PennantPark Investment (NASDAQ:PNNT) on 8/14/2023 |
MRNS Marinus Pharmaceuticals | $1.40 -3.5% | 8/11/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Buy | $17.00 -> $13.00 | Low | View details for LADENBURG THALM/SH SH rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 8/11/2023 |
SLRC SLR Investment | $15.96 -0.1% | 8/11/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of SLR Investment (NASDAQ:SLRC) on 8/11/2023 |
HROW Harrow | $17.65 -0.2% | 8/10/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $33.70 -> $34.40 | Low | View details for LADENBURG THALM/SH SH rating of Harrow (NASDAQ:HROW) on 8/10/2023 |
SSKN STRATA Skin Sciences | $3.14 -0.6% | 8/10/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $41.00 -> $38.00 | N/A | View details for LADENBURG THALM/SH SH rating of STRATA Skin Sciences (NASDAQ:SSKN) on 8/10/2023 |
SO Southern | $77.94 +0.3% | 8/9/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $72.00 | Low | View details for LADENBURG THALM/SH SH rating of Southern (NYSE:SO) on 8/9/2023 |
WHF WhiteHorse Finance | $12.45 -4.6% | 8/9/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $13.00 | Low | View details for LADENBURG THALM/SH SH rating of WhiteHorse Finance (NASDAQ:WHF) on 8/9/2023 |
HTGC Hercules Capital | $19.57 -0.1% | 8/4/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $17.00 -> $18.50 | Low | View details for LADENBURG THALM/SH SH rating of Hercules Capital (NYSE:HTGC) on 8/4/2023 |
ARDX Ardelyx | $5.95 -5.4% | 8/3/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $7.50 -> $8.50 | Low | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 8/3/2023 |
CORT Corcept Therapeutics | $28.15 -1.5% | 8/3/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $44.00 -> $47.50 | Low | View details for LADENBURG THALM/SH SH rating of Corcept Therapeutics (NASDAQ:CORT) on 8/3/2023 |
UTHR United Therapeutics | $306.04 +3.0% | 8/3/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy -> Buy | $256.00 -> $268.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 8/3/2023 |
URGN UroGen Pharma | $16.87 -7.7% | 7/31/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $47.00 -> $52.00 | Low | View details for LADENBURG THALM/SH SH rating of UroGen Pharma (NASDAQ:URGN) on 7/31/2023 |
NWE NorthWestern Energy Group | $49.40 -0.3% | 7/27/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $57.00 -> $59.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 7/27/2023 |
BLDE Blade Air Mobility | $3.35 +7.0% | 7/17/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $13.00 | Low | View details for LADENBURG THALM/SH SH rating of Blade Air Mobility (NASDAQ:BLDE) on 7/17/2023 |
CRVS Corvus Pharmaceuticals | $1.87 -3.1% | 7/10/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $10.00 -> $12.00 | Low | View details for LADENBURG THALM/SH SH rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 7/10/2023 |
LPTH LightPath Technologies | $1.22 -1.6% | 6/30/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | Low | View details for LADENBURG THALM/SH SH rating of LightPath Technologies (NASDAQ:LPTH) on 6/30/2023 |
LNT Alliant Energy | $49.62 -0.1% | 6/16/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $52.50 | Low | View details for LADENBURG THALM/SH SH rating of Alliant Energy (NASDAQ:LNT) on 6/16/2023 |
OGE OGE Energy | $35.11 -0.1% | 6/15/2023 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $37.00 -> $39.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 6/15/2023 |
NWE NorthWestern Energy Group | $49.40 -0.3% | 6/14/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $57.50 -> $57.00 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 6/14/2023 |
CRVS Corvus Pharmaceuticals | $1.87 -3.1% | 5/30/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $4.00 -> $10.00 | Low | View details for LADENBURG THALM/SH SH rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 5/30/2023 |
CKPT Checkpoint Therapeutics | $1.94 -4.4% | 5/17/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $69.00 -> $65.00 | Low | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 5/17/2023 |
EIX Edison International | $71.39 -0.2% | 5/17/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $66.00 -> $67.00 | Low | View details for LADENBURG THALM/SH SH rating of Edison International (NYSE:EIX) on 5/17/2023 |
NWE NorthWestern Energy Group | $49.40 -0.3% | 5/17/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $57.50 | Low | View details for LADENBURG THALM/SH SH rating of NorthWestern Energy Group (NYSE:NWE) on 5/17/2023 |
HROW Harrow | $17.65 -0.2% | 5/12/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $27.20 -> $32.40 | Low | View details for LADENBURG THALM/SH SH rating of Harrow (NASDAQ:HROW) on 5/12/2023 |
CDXC ChromaDex | $2.75 -7.1% | 5/11/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $7.50 -> $6.60 | Low | View details for LADENBURG THALM/SH SH rating of ChromaDex (NASDAQ:CDXC) on 5/11/2023 |
AADI Aadi Bioscience | $1.61 -1.2% | 5/11/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $47.00 -> $33.00 | Low | View details for LADENBURG THALM/SH SH rating of Aadi Bioscience (NASDAQ:AADI) on 5/11/2023 |
BNGO Bionano Genomics | $0.78 -4.9% | 5/10/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $60.00 -> $48.00 | Low | View details for LADENBURG THALM/SH SH rating of Bionano Genomics (NASDAQ:BNGO) on 5/10/2023 |
CELH Celsius | $63.28 +8.3% | 5/10/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $36.67 -> $40.67 | Low | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 5/10/2023 |
SNCR Synchronoss Technologies | $7.75 -6.4% | 5/10/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $41.40 -> $36.00 | Low | View details for LADENBURG THALM/SH SH rating of Synchronoss Technologies (NASDAQ:SNCR) on 5/10/2023 |
SAR Saratoga Investment | $22.97 -0.1% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $28.00 -> $27.00 | Low | View details for LADENBURG THALM/SH SH rating of Saratoga Investment (NYSE:SAR) on 5/4/2023 |
OPK OPKO Health | $1.26 +0.8% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $5.75 -> $5.40 | Low | View details for LADENBURG THALM/SH SH rating of OPKO Health (NASDAQ:OPK) on 5/4/2023 |
TPVG TriplePoint Venture Growth BDC | $8.82 +0.8% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $14.50 -> $13.50 | Low | View details for LADENBURG THALM/SH SH rating of TriplePoint Venture Growth BDC (NYSE:TPVG) on 5/4/2023 |
UTHR United Therapeutics | $306.04 +3.0% | 5/4/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $285.00 -> $256.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 5/4/2023 |
AVDL Avadel Pharmaceuticals | $15.60 -0.6% | 5/2/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $14.50 -> $16.00 | Low | View details for LADENBURG THALM/SH SH rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 5/2/2023 |
Bigger Than NVIDIA? (Ad) With NVIDIA flying high, everyone is looking for the next breakout stock.
But right now...
There's only ONE stock you should be watching. Get the full story here >>> |
VICI VICI Properties | $28.11 +1.2% | 5/1/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $34.50 -> $37.00 | Low | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 5/1/2023 |
TPST Tempest Therapeutics | $2.85 -2.1% | 4/28/2023 | Target Raised by | LADENBURG THALM/SH SH | - | | $8.00 -> $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Tempest Therapeutics (NASDAQ:TPST) on 4/28/2023 |
ACRV Acrivon Therapeutics | $6.63 -3.6% | 4/27/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $22.00 | Low | View details for LADENBURG THALM/SH SH rating of Acrivon Therapeutics (NASDAQ:ACRV) on 4/27/2023 |
OGE OGE Energy | $35.11 -0.1% | 4/20/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $37.00 | Low | View details for LADENBURG THALM/SH SH rating of OGE Energy (NYSE:OGE) on 4/20/2023 |
HRZN Horizon Technology Finance | $11.77 -0.3% | 4/11/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $12.50 | Low | View details for LADENBURG THALM/SH SH rating of Horizon Technology Finance (NASDAQ:HRZN) on 4/11/2023 |
SCYX SCYNEXIS | $1.89 -6.0% | 4/3/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $15.00 | Low | View details for LADENBURG THALM/SH SH rating of SCYNEXIS (NASDAQ:SCYX) on 4/3/2023 |
MFIN Medallion Financial | $7.83 -3.5% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Medallion Financial (NASDAQ:MFIN) on 4/3/2023 |
EIX Edison International | $71.39 -0.2% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Sell | $66.00 | Low | View details for LADENBURG THALM/SH SH rating of Edison International (NYSE:EIX) on 4/3/2023 |
ETR Entergy | $106.08 -0.3% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $116.00 | Low | View details for LADENBURG THALM/SH SH rating of Entergy (NYSE:ETR) on 4/3/2023 |
AEP American Electric Power | $87.55 -0.2% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Sell | $82.50 | Low | View details for LADENBURG THALM/SH SH rating of American Electric Power (NASDAQ:AEP) on 4/3/2023 |
CKPT Checkpoint Therapeutics | $1.94 -4.4% | 4/3/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $96.00 -> $69.00 | Low | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 4/3/2023 |
PEG Public Service Enterprise Group | $73.30 +0.3% | 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | $60.50 | Low | View details for LADENBURG THALM/SH SH rating of Public Service Enterprise Group (NYSE:PEG) on 4/3/2023 |
PCG PG&E | $17.78
| 4/3/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $20.50 | Low | View details for LADENBURG THALM/SH SH rating of PG&E (NYSE:PCG) on 4/3/2023 |
ZYXI Zynex | $9.14 +0.3% | 3/28/2023 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $27.00 -> $28.00 | Low | View details for LADENBURG THALM/SH SH rating of Zynex (NASDAQ:ZYXI) on 3/28/2023 |
EPRT Essential Properties Realty Trust | $27.24 -1.5% | 3/23/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $28.00 -> $27.00 | Low | View details for LADENBURG THALM/SH SH rating of Essential Properties Realty Trust (NYSE:EPRT) on 3/23/2023 |
EMAN eMagin | $2.07
| 3/16/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $3.00 | N/A | View details for LADENBURG THALM/SH SH rating of eMagin (NYSEAMERICAN:EMAN) on 3/16/2023 |
VRDN Viridian Therapeutics | $12.18 -0.2% | 3/9/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $40.00 | Low | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 3/9/2023 |
ADVM Adverum Biotechnologies | $6.59 -10.0% | 3/7/2023 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $20.00 | Low | View details for LADENBURG THALM/SH SH rating of Adverum Biotechnologies (NASDAQ:ADVM) on 3/7/2023 |
RYTM Rhythm Pharmaceuticals | $41.39 +0.6% | 3/2/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $35.00 | Low | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 3/2/2023 |
NYMT New York Mortgage Trust | $6.03 -0.3% | 2/24/2023 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $12.00 | Low | View details for LADENBURG THALM/SH SH rating of New York Mortgage Trust (NASDAQ:NYMT) on 2/24/2023 |
UTHR United Therapeutics | $306.04 +3.0% | 2/23/2023 | Target Lowered by | LADENBURG THALM/SH SH | - | | $295.00 -> $285.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 2/23/2023 |
KPRX Kiora Pharmaceuticals | $4.29 +1.4% | 2/8/2023 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $1,071.00 | Low | View details for LADENBURG THALM/SH SH rating of Kiora Pharmaceuticals (NASDAQ:KPRX) on 2/8/2023 |
NRBO NeuroBo Pharmaceuticals | $3.84 +0.3% | 12/7/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | Low | View details for LADENBURG THALM/SH SH rating of NeuroBo Pharmaceuticals (NASDAQ:NRBO) on 12/7/2022 |
WHF WhiteHorse Finance | $12.45 -4.6% | 11/17/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $14.00 | Low | View details for LADENBURG THALM/SH SH rating of WhiteHorse Finance (NASDAQ:WHF) on 11/17/2022 |
CMPX Compass Therapeutics | $1.12 -4.3% | 11/16/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $9.00 | Low | View details for LADENBURG THALM/SH SH rating of Compass Therapeutics (NASDAQ:CMPX) on 11/16/2022 |
SNCR Synchronoss Technologies | $7.75 -6.4% | 11/15/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $41.40 | Low | View details for LADENBURG THALM/SH SH rating of Synchronoss Technologies (NASDAQ:SNCR) on 11/15/2022 |
LPCN Lipocine | $7.18 -32.8% | 11/15/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $68.00 | Low | View details for LADENBURG THALM/SH SH rating of Lipocine (NASDAQ:LPCN) on 11/15/2022 |
AADI Aadi Bioscience | $1.61 -1.2% | 11/15/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $47.00 | N/A | View details for LADENBURG THALM/SH SH rating of Aadi Bioscience (NASDAQ:AADI) on 11/15/2022 |
MDV Modiv Industrial | $14.66 -1.1% | 11/11/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $18.50 | Low | View details for LADENBURG THALM/SH SH rating of Modiv Industrial (NYSE:MDV) on 11/11/2022 |
NXTC NextCure | $1.32 -7.7% | 11/4/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of NextCure (NASDAQ:NXTC) on 11/4/2022 |
GAIN Gladstone Investment | $13.84 -1.2% | 11/2/2022 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Gladstone Investment (NASDAQ:GAIN) on 11/2/2022 |
GTY Getty Realty | $26.57 -0.4% | 11/1/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $35.50 -> $34.00 | Low | View details for LADENBURG THALM/SH SH rating of Getty Realty (NYSE:GTY) on 11/1/2022 |
CAPR Capricor Therapeutics | $4.84 -2.4% | 10/26/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $15.00 | Low | View details for LADENBURG THALM/SH SH rating of Capricor Therapeutics (NASDAQ:CAPR) on 10/26/2022 |
VICI VICI Properties | $28.11 +1.2% | 10/12/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $36.00 -> $34.50 | Low | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 10/12/2022 |
CRVS Corvus Pharmaceuticals | $1.87 -3.1% | 10/7/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $2.00 | Low | View details for LADENBURG THALM/SH SH rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 10/7/2022 |
TPST Tempest Therapeutics | $2.85 -2.1% | 9/15/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $8.00 | Low | View details for LADENBURG THALM/SH SH rating of Tempest Therapeutics (NASDAQ:TPST) on 9/15/2022 |
PTN Palatin Technologies | $2.07 +13.7% | 9/9/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $50.00 | Low | View details for LADENBURG THALM/SH SH rating of Palatin Technologies (NYSEAMERICAN:PTN) on 9/9/2022 |
IMCR Immunocore | $35.94 -2.8% | 9/8/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $82.00 | Low | View details for LADENBURG THALM/SH SH rating of Immunocore (NASDAQ:IMCR) on 9/8/2022 |
BLIN Bridgeline Digital | $1.00 -5.7% | 9/7/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $4.50 | Low | View details for LADENBURG THALM/SH SH rating of Bridgeline Digital (NASDAQ:BLIN) on 9/7/2022 |
KPRX Kiora Pharmaceuticals | $4.29 +1.4% | 8/25/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | Low | View details for LADENBURG THALM/SH SH rating of Kiora Pharmaceuticals (NASDAQ:KPRX) on 8/25/2022 |
VRDN Viridian Therapeutics | $12.18 -0.2% | 8/16/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $33.00 -> $40.00 | Low | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 8/16/2022 |
ORC Orchid Island Capital | $8.46 -0.6% | 8/15/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Orchid Island Capital (NYSE:ORC) on 8/15/2022 |
WRAP Wrap Technologies | $1.58 +18.8% | 8/12/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $4.25 -> $2.10 | Low | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 8/12/2022 |
ORC Orchid Island Capital | $8.46 -0.6% | 8/8/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Low | View details for LADENBURG THALM/SH SH rating of Orchid Island Capital (NYSE:ORC) on 8/8/2022 |
FBIO Fortress Biotech | $1.79 -5.8% | 8/4/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $90.00 | Low | View details for LADENBURG THALM/SH SH rating of Fortress Biotech (NASDAQ:FBIO) on 8/4/2022 |
VICI VICI Properties | $28.11 +1.2% | 7/27/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $33.50 -> $36.00 | Low | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 7/27/2022 |
ANEB Anebulo Pharmaceuticals | $2.05 +1.0% | 7/27/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $6.00 | Low | View details for LADENBURG THALM/SH SH rating of Anebulo Pharmaceuticals (NASDAQ:ANEB) on 7/27/2022 |
LQDA Liquidia | $12.52 -6.1% | 7/22/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $15.00 | Low | View details for LADENBURG THALM/SH SH rating of Liquidia (NASDAQ:LQDA) on 7/22/2022 |
RYTM Rhythm Pharmaceuticals | $41.39 +0.6% | 7/13/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $15.00 -> $23.00 | Low | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 7/13/2022 |
NVCT Nuvectis Pharma | $6.45 -5.8% | 7/13/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $21.00 | N/A | View details for LADENBURG THALM/SH SH rating of Nuvectis Pharma (NASDAQ:NVCT) on 7/13/2022 |
This Weight Loss Company Can't Make Enough Product (Ad) A tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel.
They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December! Get the name of the company and their stock ticker here >>> |
XAIR Beyond Air | $1.26 -3.8% | 6/29/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $17.00 -> $23.00 | Low | View details for LADENBURG THALM/SH SH rating of Beyond Air (NASDAQ:XAIR) on 6/29/2022 |
CORZ Core Scientific | $8.91 -8.0% | 5/31/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $18.75 -> $15.00 | High | View details for LADENBURG THALM/SH SH rating of Core Scientific (NASDAQ:CORZ) on 5/31/2022 |
PAYS Paysign | $3.87 -0.8% | 5/17/2022 | Target Raised by | LADENBURG THALM/SH SH | - | Neutral -> NA | $2.80 | Medium | View details for LADENBURG THALM/SH SH rating of Paysign (NASDAQ:PAYS) on 5/17/2022 |
PHGE BiomX | $0.34 +3.1% | 5/12/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | | $13.00 -> $8.00 | N/A | View details for LADENBURG THALM/SH SH rating of BiomX (NYSEMKT:PHGE) on 5/12/2022 |
CELH Celsius | $63.28 +8.3% | 5/11/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $37.83 -> $40.00 | High | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 5/11/2022 |
ANVS Annovis Bio | $5.31 -3.6% | 5/2/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Annovis Bio (NYSE:ANVS) on 5/2/2022 |
RWAY Runway Growth Finance | $11.71 -0.3% | 4/22/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $15.50 | Low | View details for LADENBURG THALM/SH SH rating of Runway Growth Finance (NASDAQ:RWAY) on 4/22/2022 |
CGTX Cognition Therapeutics | $2.01 -8.2% | 4/22/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $10.00 | Low | View details for LADENBURG THALM/SH SH rating of Cognition Therapeutics (NASDAQ:CGTX) on 4/22/2022 |
PAYS Paysign | $3.87 -0.8% | 3/24/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Paysign (NASDAQ:PAYS) on 3/24/2022 |
LFT Lument Finance Trust | $2.48 -0.8% | 3/17/2022 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Lument Finance Trust (NYSE:LFT) on 3/17/2022 |
CMPX Compass Therapeutics | $1.12 -4.3% | 3/15/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $7.00 | N/A | View details for LADENBURG THALM/SH SH rating of Compass Therapeutics (NASDAQ:CMPX) on 3/15/2022 |
WRAP Wrap Technologies | $1.58 +18.8% | 3/11/2022 | Target Lowered by | LADENBURG THALM/SH SH | Analyst Jon Hickman | Buy | $6.25 -> $5.25 | High | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 3/11/2022 |
SPRB Spruce Biosciences | $0.63 -3.1% | 3/8/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $6.00 | High | View details for LADENBURG THALM/SH SH rating of Spruce Biosciences (NASDAQ:SPRB) on 3/8/2022 |
EPRT Essential Properties Realty Trust | $27.24 -1.5% | 3/1/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $27.00 -> $28.50 | Low | View details for LADENBURG THALM/SH SH rating of Essential Properties Realty Trust (NYSE:EPRT) on 3/1/2022 |
NXTC NextCure | $1.32 -7.7% | 3/1/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $16.00 | Low | View details for LADENBURG THALM/SH SH rating of NextCure (NASDAQ:NXTC) on 3/1/2022 |
UTHR United Therapeutics | $306.04 +3.0% | 2/25/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $231.00 -> $203.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 2/25/2022 |
BYRN Byrna Technologies | $10.57 -1.1% | 2/22/2022 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $26.50 -> $14.00 | Low | View details for LADENBURG THALM/SH SH rating of Byrna Technologies (NASDAQ:BYRN) on 2/22/2022 |
RYTM Rhythm Pharmaceuticals | $41.39 +0.6% | 2/17/2022 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $15.00 | High | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 2/17/2022 |
CKPT Checkpoint Therapeutics | $1.94 -4.4% | 1/26/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $200.00 -> $260.00 | Medium | View details for LADENBURG THALM/SH SH rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 1/26/2022 |
HCCC Healthcare Capital | $12.74 +10.8% | 1/24/2022 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $18.00 | Low | View details for LADENBURG THALM/SH SH rating of Healthcare Capital (OTCMKTS:HCCC) on 1/24/2022 |
SRAX SRAX | $0.29 -27.5% | 1/11/2022 | Target Raised by | LADENBURG THALM/SH SH | - | | $12.00 -> $13.50 | High | View details for LADENBURG THALM/SH SH rating of SRAX (NASDAQ:SRAX) on 1/11/2022 |
VRDN Viridian Therapeutics | $12.18 -0.2% | 12/21/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $36.00 | High | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/21/2021 |
ARDX Ardelyx | $5.95 -5.4% | 12/1/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $6.00 | High | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 12/1/2021 |
RPHM Reneo Pharmaceuticals | $1.58 -4.2% | 11/22/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $45.00 | Medium | View details for LADENBURG THALM/SH SH rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 11/22/2021 |
BWAY BrainsWay | $6.09 +1.0% | 11/17/2021 | Target Raised by | LADENBURG THALM/SH SH | Analyst Jeffrey Cohen | Buy | $16.00 -> $17.00 | Low | View details for LADENBURG THALM/SH SH rating of BrainsWay (NASDAQ:BWAY) on 11/17/2021 |
WRAP Wrap Technologies | $1.58 +18.8% | 10/29/2021 | Target Lowered by | LADENBURG THALM/SH SH | Analyst Jon Hickman | Buy | $9.40 -> $6.75 | Medium | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 10/29/2021 |
PHGE BiomX | $0.34 +3.1% | 10/19/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $19.00 | N/A | View details for LADENBURG THALM/SH SH rating of BiomX (NYSEMKT:PHGE) on 10/19/2021 |
ARDX Ardelyx | $5.95 -5.4% | 10/14/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 10/14/2021 |
BCYP Big Cypress Acquisition | $8.44 -19.2% | 10/1/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $16.50 | Low | View details for LADENBURG THALM/SH SH rating of Big Cypress Acquisition (OTCMKTS:BCYP) on 10/1/2021 |
PTN Palatin Technologies | $2.07 +13.7% | 9/30/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $50.00 | N/A | View details for LADENBURG THALM/SH SH rating of Palatin Technologies (NYSEAMERICAN:PTN) on 9/30/2021 |
AADI Aadi Bioscience | $1.61 -1.2% | 9/14/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $51.00 | Low | View details for LADENBURG THALM/SH SH rating of Aadi Bioscience (NASDAQ:AADI) on 9/14/2021 |
FBRX Forte Biosciences | $0.54 +3.9% | 9/3/2021 | Downgraded by | LADENBURG THALM/SH SH | Analyst Michael Higgins | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Forte Biosciences (NASDAQ:FBRX) on 9/3/2021 |
LRFC Logan Ridge Finance | $22.43 +0.4% | 8/17/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $32.00 | High | View details for LADENBURG THALM/SH SH rating of Logan Ridge Finance (NASDAQ:LRFC) on 8/17/2021 |
PAYS Paysign | $3.87 -0.8% | 8/12/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $3.50 -> $3.75 | High | View details for LADENBURG THALM/SH SH rating of Paysign (NASDAQ:PAYS) on 8/12/2021 |
LFT Lument Finance Trust | $2.48 -0.8% | 8/10/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $4.50 | High | View details for LADENBURG THALM/SH SH rating of Lument Finance Trust (NYSE:LFT) on 8/10/2021 |
PFLT PennantPark Floating Rate Capital | $11.23 -0.4% | 8/9/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $13.50 | Low | View details for LADENBURG THALM/SH SH rating of PennantPark Floating Rate Capital (NASDAQ:PFLT) on 8/9/2021 |
OFS OFS Capital | $9.42 -4.4% | 8/9/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $11.50 | Medium | View details for LADENBURG THALM/SH SH rating of OFS Capital (NASDAQ:OFS) on 8/9/2021 |
RYTM Rhythm Pharmaceuticals | $41.39 +0.6% | 8/4/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 8/4/2021 |
IMMP Immutep | $2.57 -4.5% | 8/3/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $8.30 | Medium | View details for LADENBURG THALM/SH SH rating of Immutep (NASDAQ:IMMP) on 8/3/2021 |
ECOR electroCore | $5.77 -8.0% | 7/27/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $13.95 | Low | View details for LADENBURG THALM/SH SH rating of electroCore (NASDAQ:ECOR) on 7/27/2021 |
LAND Gladstone Land | $13.30 -1.4% | 7/21/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of Gladstone Land (NASDAQ:LAND) on 7/21/2021 |
ARDX Ardelyx | $5.95 -5.4% | 7/20/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $6.50 -> $15.00 | N/A | View details for LADENBURG THALM/SH SH rating of Ardelyx (NASDAQ:ARDX) on 7/20/2021 |
HROW Harrow | $17.65 -0.2% | 7/2/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $14.25 | Medium | View details for LADENBURG THALM/SH SH rating of Harrow (NASDAQ:HROW) on 7/2/2021 |
SNCR Synchronoss Technologies | $7.75 -6.4% | 6/23/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $66.60 | High | View details for LADENBURG THALM/SH SH rating of Synchronoss Technologies (NASDAQ:SNCR) on 6/23/2021 |
EVAX Evaxion Biotech A/S | $2.73 +10.5% | 6/23/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $230.00 | High | View details for LADENBURG THALM/SH SH rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 6/23/2021 |
XAIR Beyond Air | $1.26 -3.8% | 6/22/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $17.00 | Low | View details for LADENBURG THALM/SH SH rating of Beyond Air (NASDAQ:XAIR) on 6/22/2021 |
OPK OPKO Health | $1.26 +0.8% | 6/21/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $7.00 | Medium | View details for LADENBURG THALM/SH SH rating of OPKO Health (NASDAQ:OPK) on 6/21/2021 |
AYTU Aytu BioPharma | $2.85 +1.4% | 6/18/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $14.50 | High | View details for LADENBURG THALM/SH SH rating of Aytu BioPharma (NASDAQ:AYTU) on 6/18/2021 |
GRWG GrowGeneration | $2.41 +0.4% | 5/14/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $45.00 | High | View details for LADENBURG THALM/SH SH rating of GrowGeneration (NASDAQ:GRWG) on 5/14/2021 |
TSLX Sixth Street Specialty Lending | $21.18 -0.2% | 5/12/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Sixth Street Specialty Lending (NYSE:TSLX) on 5/12/2021 |
Kiss of death from Joe Biden (Ad) Biden cannot lose this election.
A bombshell new documentary exposes how the D.C establishment has engineered an “electoral failsafe” that all but guarantees Democratic victory… not just in 2024 but every future election. I have uncovered a bombshell that changes everything… and threatens everything. |
ATXS Astria Therapeutics | $8.99 +1.8% | 5/12/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $36.00 | High | View details for LADENBURG THALM/SH SH rating of Astria Therapeutics (NASDAQ:ATXS) on 5/12/2021 |
PAYS Paysign | $3.87 -0.8% | 5/12/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | $3.50 | High | View details for LADENBURG THALM/SH SH rating of Paysign (NASDAQ:PAYS) on 5/12/2021 |
TRIN Trinity Capital | $14.88 +0.1% | 5/7/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $17.00 | Medium | View details for LADENBURG THALM/SH SH rating of Trinity Capital (NASDAQ:TRIN) on 5/7/2021 |
TSLX Sixth Street Specialty Lending | $21.18 -0.2% | 5/6/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of Sixth Street Specialty Lending (NYSE:TSLX) on 5/6/2021 |
BYRN Byrna Technologies | $10.57 -1.1% | 5/3/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $26.50 | Low | View details for LADENBURG THALM/SH SH rating of Byrna Technologies (NASDAQ:BYRN) on 5/3/2021 |
OXSQ Oxford Square Capital | $2.98 -0.7% | 5/3/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of Oxford Square Capital (NASDAQ:OXSQ) on 5/3/2021 |
WRAP Wrap Technologies | $1.58 +18.8% | 5/3/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $26.50 | Low | View details for LADENBURG THALM/SH SH rating of Wrap Technologies (NASDAQ:WRAP) on 5/3/2021 |
RTX RTX | $104.77 +0.3% | 5/3/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $100.00 | Low | View details for LADENBURG THALM/SH SH rating of RTX (NYSE:RTX) on 5/3/2021 |
GLPI Gaming and Leisure Properties | $44.14 +1.1% | 4/26/2021 | Target Raised by | LADENBURG THALM/SH SH | - | | $47.50 -> $51.00 | Low | View details for LADENBURG THALM/SH SH rating of Gaming and Leisure Properties (NASDAQ:GLPI) on 4/26/2021 |
VICI VICI Properties | $28.11 +1.2% | 4/26/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $28.00 -> $33.50 | Medium | View details for LADENBURG THALM/SH SH rating of VICI Properties (NYSE:VICI) on 4/26/2021 |
NNOX Nano-X Imaging | $7.23 -4.1% | 4/26/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $52.00 | Low | View details for LADENBURG THALM/SH SH rating of Nano-X Imaging (NASDAQ:NNOX) on 4/26/2021 |
AFCG AFC Gamma | $12.43 -0.9% | 4/19/2021 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of AFC Gamma (NASDAQ:AFCG) on 4/19/2021 |
NNOX Nano-X Imaging | $7.23 -4.1% | 4/19/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Nano-X Imaging (NASDAQ:NNOX) on 4/19/2021 |
PHGE BiomX | $0.34 +3.1% | 4/15/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $25.00 | N/A | View details for LADENBURG THALM/SH SH rating of BiomX (NYSEMKT:PHGE) on 4/15/2021 |
AFCG AFC Gamma | $12.43 -0.9% | 4/12/2021 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of AFC Gamma (NASDAQ:AFCG) on 4/12/2021 |
IZEA IZEA Worldwide | $2.01 -5.2% | 4/6/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Sell -> Neutral | $18.00 | Medium | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 4/6/2021 |
OXSQ Oxford Square Capital | $2.98 -0.7% | 3/23/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Oxford Square Capital (NASDAQ:OXSQ) on 3/23/2021 |
CELH Celsius | $63.28 +8.3% | 3/11/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 3/11/2021 |
EVAX Evaxion Biotech A/S | $2.73 +10.5% | 3/2/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 3/2/2021 |
TRIN Trinity Capital | $14.88 +0.1% | 2/23/2021 | Initiated by | LADENBURG THALM/SH SH | - | Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of Trinity Capital (NASDAQ:TRIN) on 2/23/2021 |
ARR ARMOUR Residential REIT | $19.10 -1.2% | 2/18/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of ARMOUR Residential REIT (NYSE:ARR) on 2/18/2021 |
OTLK Outlook Therapeutics | $7.07 -6.5% | 2/17/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $120.00 | Low | View details for LADENBURG THALM/SH SH rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/17/2021 |
AVXL Anavex Life Sciences | $3.88 +4.0% | 2/17/2021 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $20.00 | Low | View details for LADENBURG THALM/SH SH rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/17/2021 |
SRAX SRAX | $0.29 -27.5% | 2/8/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $3.50 | High | View details for LADENBURG THALM/SH SH rating of SRAX (NASDAQ:SRAX) on 2/8/2021 |
APPS Digital Turbine | $1.44 -5.3% | 2/4/2021 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Digital Turbine (NASDAQ:APPS) on 2/4/2021 |
JUSHF Jushi | $0.59 +5.4% | 2/4/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Jushi (OTCMKTS:JUSHF) on 2/4/2021 |
RYTM Rhythm Pharmaceuticals | $41.39 +0.6% | 1/27/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Positive -> Buy | $43.00 -> $60.00 | High | View details for LADENBURG THALM/SH SH rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 1/27/2021 |
IZEA IZEA Worldwide | $2.01 -5.2% | 1/26/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral -> Sell | | Medium | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 1/26/2021 |
PSTV Plus Therapeutics | $1.93 -3.5% | 1/25/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $120.00 | High | View details for LADENBURG THALM/SH SH rating of Plus Therapeutics (NASDAQ:PSTV) on 1/25/2021 |
VRDN Viridian Therapeutics | $12.18 -0.2% | 1/25/2021 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $40.00 | Low | View details for LADENBURG THALM/SH SH rating of Viridian Therapeutics (NASDAQ:VRDN) on 1/25/2021 |
UTHR United Therapeutics | $306.04 +3.0% | 1/20/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Positive -> Buy | $151.00 -> $199.00 | Low | View details for LADENBURG THALM/SH SH rating of United Therapeutics (NASDAQ:UTHR) on 1/20/2021 |
VCEL Vericel | $43.37 +4.0% | 1/19/2021 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $27.50 -> $44.00 | Low | View details for LADENBURG THALM/SH SH rating of Vericel (NASDAQ:VCEL) on 1/19/2021 |
GRWG GrowGeneration | $2.41 +0.4% | 1/12/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of GrowGeneration (NASDAQ:GRWG) on 1/12/2021 |
SAR Saratoga Investment | $22.97 -0.1% | 1/7/2021 | Target Raised by | LADENBURG THALM/SH SH | - | In-Line -> Buy | $21.00 -> $25.00 | Low | View details for LADENBURG THALM/SH SH rating of Saratoga Investment (NYSE:SAR) on 1/7/2021 |
TPST Tempest Therapeutics | $2.85 -2.1% | 1/6/2021 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Tempest Therapeutics (NASDAQ:TPST) on 1/6/2021 |
IIPR Innovative Industrial Properties | $108.46 +0.9% | 12/23/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | N/A | View details for LADENBURG THALM/SH SH rating of Innovative Industrial Properties (NYSE:IIPR) on 12/23/2020 |
VERB Verb Technology | $0.12 -7.8% | 12/14/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Verb Technology (NASDAQ:VERB) on 12/14/2020 |
GLPI Gaming and Leisure Properties | $44.14 +1.1% | 12/11/2020 | Target Raised by | LADENBURG THALM/SH SH | - | | $31.50 -> $47.50 | Medium | View details for LADENBURG THALM/SH SH rating of Gaming and Leisure Properties (NASDAQ:GLPI) on 12/11/2020 |
LPCN Lipocine | $7.18 -32.8% | 12/10/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $51.00 | High | View details for LADENBURG THALM/SH SH rating of Lipocine (NASDAQ:LPCN) on 12/10/2020 |
BGNE BeiGene | $154.70 -2.9% | 12/8/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | $278.00 | Low | View details for LADENBURG THALM/SH SH rating of BeiGene (NASDAQ:BGNE) on 12/8/2020 |
OVID Ovid Therapeutics | $0.79
| 12/2/2020 | Target Lowered by | LADENBURG THALM/SH SH | - | Buy | $21.00 -> $7.00 | High | View details for LADENBURG THALM/SH SH rating of Ovid Therapeutics (NASDAQ:OVID) on 12/2/2020 |
PNNT PennantPark Investment | $7.46 -0.5% | 11/20/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | Medium | View details for LADENBURG THALM/SH SH rating of PennantPark Investment (NASDAQ:PNNT) on 11/20/2020 |
PFLT PennantPark Floating Rate Capital | $11.23 -0.4% | 11/19/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | Low | View details for LADENBURG THALM/SH SH rating of PennantPark Floating Rate Capital (NASDAQ:PFLT) on 11/19/2020 |
ECC Eagle Point Credit | $10.10
| 11/18/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Buy | $8.00 -> $10.00 | Medium | View details for LADENBURG THALM/SH SH rating of Eagle Point Credit (NYSE:ECC) on 11/18/2020 |
PAYS Paysign | $3.87 -0.8% | 11/18/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Neutral -> Sell | $8.75 -> $3.30 | High | View details for LADENBURG THALM/SH SH rating of Paysign (NASDAQ:PAYS) on 11/18/2020 |
IZEA IZEA Worldwide | $2.01 -5.2% | 11/13/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of IZEA Worldwide (NASDAQ:IZEA) on 11/13/2020 |
CELH Celsius | $63.28 +8.3% | 11/13/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $7.83 -> $9.67 | Medium | View details for LADENBURG THALM/SH SH rating of Celsius (NASDAQ:CELH) on 11/13/2020 |
TARS Tarsus Pharmaceuticals | $27.28 -5.4% | 11/10/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $42.00 | High | View details for LADENBURG THALM/SH SH rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 11/10/2020 |
BGNE BeiGene | $154.70 -2.9% | 11/9/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | High | View details for LADENBURG THALM/SH SH rating of BeiGene (NASDAQ:BGNE) on 11/9/2020 |
ORC Orchid Island Capital | $8.46 -0.6% | 10/30/2020 | Upgraded by | LADENBURG THALM/SH SH | - | Neutral -> Buy | | High | View details for LADENBURG THALM/SH SH rating of Orchid Island Capital (NYSE:ORC) on 10/30/2020 |
APPS Digital Turbine | $1.44 -5.3% | 10/30/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $21.00 -> $31.50 | High | View details for LADENBURG THALM/SH SH rating of Digital Turbine (NASDAQ:APPS) on 10/30/2020 |
IMNM Immunome | $13.28 +1.0% | 10/26/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of Immunome (NASDAQ:IMNM) on 10/26/2020 |
COGT Cogent Biosciences | $8.50 -3.4% | 10/14/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $4.00 | N/A | View details for LADENBURG THALM/SH SH rating of Cogent Biosciences (NASDAQ:COGT) on 10/14/2020 |
BNTC Benitec Biopharma | $7.25 -3.2% | 10/5/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | | Medium | View details for LADENBURG THALM/SH SH rating of Benitec Biopharma (NASDAQ:BNTC) on 10/5/2020 |
AVXL Anavex Life Sciences | $3.88 +4.0% | 9/28/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $12.00 | High | View details for LADENBURG THALM/SH SH rating of Anavex Life Sciences (NASDAQ:AVXL) on 9/28/2020 |
MRNS Marinus Pharmaceuticals | $1.40 -3.5% | 9/25/2020 | Reiterated by | LADENBURG THALM/SH SH | - | Buy | $20.00 | High | View details for LADENBURG THALM/SH SH rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 9/25/2020 |
BNGO Bionano Genomics | $0.78 -4.9% | 9/24/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | $12.50 | Medium | View details for LADENBURG THALM/SH SH rating of Bionano Genomics (NASDAQ:BNGO) on 9/24/2020 |
LAND Gladstone Land | $13.30 -1.4% | 9/14/2020 | Target Raised by | LADENBURG THALM/SH SH | - | Positive -> Buy | $15.50 -> $16.50 | High | View details for LADENBURG THALM/SH SH rating of Gladstone Land (NASDAQ:LAND) on 9/14/2020 |
ACB Aurora Cannabis | $5.72 -0.7% | 9/8/2020 | Downgraded by | LADENBURG THALM/SH SH | - | Buy -> Neutral | $90.00 | High | View details for LADENBURG THALM/SH SH rating of Aurora Cannabis (NASDAQ:ACB) on 9/8/2020 |
NVNO enVVeno Medical | $4.70 -3.9% | 9/3/2020 | Initiated by | LADENBURG THALM/SH SH | - | Buy | | High | View details for LADENBURG THALM/SH SH rating of enVVeno Medical (NASDAQ:NVNO) on 9/3/2020 |